Navigation Links
Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry

EWING, N.J., June 26 /PRNewswire/ -- Berkley Life Sciences, LLC, a member company of W. R. Berkley Corporation, today announced the introduction of LS Prime. LS Prime is a uniquely innovative primary liability policy designed to address the complex risks faced by life science companies of all sizes.

LS Prime features comprehensive, worldwide products liability, clinical trial, errors and omissions, and premises operations coverages. Included with this broad protection is an array of new features and enhancements not found in most existing life science policies:

-- Medical monitoring expense coverage even in the absence of physical injury;

-- Biological agents liability coverage including cleanup costs;

-- Coverage for materials and products in the care, custody or control of the insured;

-- Blanket clinical trial coverage including coverage for personal injury, abuse or molestation, and medical expenses;

-- Products withdrawal expense, including crisis management expenses;

-- Affirmed punitive damages coverage where allowed by law;

-- Blanket additional insured options to suit customer preferences;

-- Various tail coverage features that are optional, including:

-- Extended Coverage - extends coverage period and reporting


-- Batch Liability - batches losses to a particular policy period

-- E-BERP - extends reporting period without the traditional back-

end charge, and reduces some of the traditional reporting


"LS Prime was developed to provide broad, seamless protection to life science enterprises," advised Jill Wadlund, President of Berkley Life Sciences. "The policy is comprehensive, yet scalable, so that customers purchase only the coverages they need. But LS Prime is just the beginning. We are committed to continuously listening to the needs of our customers. And we are equally committed to developing innovative, new insurance products and services to address those needs."

LS Prime will be issued in 48 states through Gemini Insurance Company, and in Rhode Island and Delaware through Nautilus Insurance Company. Both companies carry an A.M. Best Financial Strength Rating of A+ (Superior).

For additional information regarding Berkley Life Sciences or LS Prime Features & Benefits, visit or contact Emily Urban, SVP, at 609.844.7800 or

About Berkley Life Sciences, LLC

Berkley Life Sciences, LLC, a member company of W. R. Berkley Corporation, is solely dedicated to serving the needs of the life science industry, providing sophisticated, innovative insurance products and services to life science customers of all sizes.

About W. R. Berkley Corporation

Founded in 1967, W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates in five segments of the property casualty insurance business: specialty insurance, regional property casualty insurance, alternative markets, reinsurance and international.

SOURCE Berkley Life Sciences, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Biosciences Announces New Leadership
2. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
3. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
4. C3i Teams with Oracles Health Sciences Global Business Unit to Provide Customers with Clinical Training and Support Services
6. LI-COR(R) Biosciences Introduces New Tools for High Throughput Western Blotting
7. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
8. Derma Sciences MEDIHONEY(TM) Helps to Save Patients Limb
9. Edwards Lifesciences to Present at the 18th Annual Wachovia Nantucket Equity Conference
10. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
11. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and ... clinical trial team. , Using the CONSULT module, patients and physicians can schedule a ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):